Identified Molecular Markers Will Bring Precision to Treatment of Retinoblastoma
September 23, 2022
New genes implicated in disease create new therapeutic targets and ability to assess disease severity.
Content related to Eye on Research: A New Way to Detect and Study Retinoblastoma
Why Are Some Retinoblastoma Tumors More Aggressive?
September 23, 2022
A new study finds a reason, paving the way for the development of new, more effective treatments.
Children’s Hospital Los Angeles Develops Liquid Biopsy Test for Pediatric Solid Tumors
March 1, 2023
A single blood test can detect various tumor types less invasively than tissue biopsy.
Jesse Berry, MD
January 29, 2020
Tenacious, caring and passionate about better ways to treat retinoblastoma, Dr. Jesse Berry is leading change in the diagnosis and treatment of this rare cancer.
A Higher Resolution Image of Human Lung Development
October 17, 2019
The invention of interactive map applications has revolutionized wayfinding, providing an unprecedented level of information far beyond what printed road maps can offer. Researchers at Children’s
When Good Macrophages go Bad
December 5, 2018
New study reveals how cancer manipulates our immune system to become harder to treat Many factors affect cancer treatment outcome, such as the size and location of the tumor, availability of effective
RB or Not RB
July 10, 2015
Retinoblastoma is a common eye cancer in children. David Cobrinik of The Vision Center has helped answer the question of why mutations to the RB1 gene primarily cause tumors of the retina.
Children’s Hospital Los Angeles Team Identifies Developmental Stage for No. 1 Eye Tumor in Children
September 19, 2018
Investigators at Children's Hospital Los Angeles have been able to pinpoint the exact stage of development of the human retina, when cells can grow out of control and form cancer-like masses. The
Oncoproteins Interact to Promote Cancer Cell Growth in Retinoblastoma
October 17, 2016
Microscopic image: MDM2 expression (in red) in retinoblastoma Rb176 cells. Credit: Donglai Qi, PhD, and David Cobrinik, MD, PhD. Researchers at The Saban Research Institute of Children’s Hospital Los